AP
Amylyx Pharmaceuticals Inc
🇺🇸XNAS.AMLXUnited StatesHealthcare
$32.90USDdown -0.74 (-2.2%)OpenEnd of day5:05 PM
Price$32.90-0.74 (-2.2%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US03237H1014
- CUSIP
- 032108508
Company
- Employees
- 136
- Headquarters
- Cambridge, United States
- Website
- https://amylyx.com
- CEO
- Mr. Justin B. Klee
Market
- Shares outstanding
- 111.4M
- Market cap
- $3.67B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $3.67B
- EPS LTM
- -$1.36calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -24.10calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0+100%up year on year
- Net income
- -$152.09M+18.93%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$126.72M+23.52%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.